
Pfizer Secures $10 Billion Deal for Obesity Drug Developer Metsera, Outbids Novo Nordisk
Nov 09, 2025 00:37 am UTC| Business Health
Pfizer has sealed a $10 billion acquisition of obesity drug developer Metsera, marking a major victory in the rapidly expanding weight-loss drug market. The New York-based pharmaceutical giant outbid Danish rival Novo...

YPF Reports $198 Million Q3 Loss Amid Higher Tax Expenses and Declining Revenue
Nov 08, 2025 03:14 am UTC| Business Economy
Argentinas state-controlled energy giant YPF reported a net loss of $198 million in the third quarter of 2025, reversing its profit from the previous year. The company attributed the loss primarily to a significant rise in...

Qcells Furloughs 1,000 Georgia Workers Amid U.S. Customs Delays on Solar Components
Nov 08, 2025 03:11 am UTC| Business
Qcells, the U.S. solar manufacturing arm of South Koreas Hanwha Group, has temporarily furloughed about 1,000 employees at its Georgia factories due to prolonged customs delays on imported solar components. The company...

Sam Altman Urges U.S. to Expand Chips Act Tax Credit for AI Growth
Nov 08, 2025 03:03 am UTC| Business Technology
OpenAI CEO Sam Altman has renewed his call for the U.S. government to broaden the scope of the Chips Act tax credit, emphasizing the need to strengthen Americas position as a global leader in artificial intelligence....

Amazon Expands Amazon Bazaar to 14 New Markets to Challenge Shein and Temu
Nov 08, 2025 01:56 am UTC| Business
Amazon has broadened its budget shopping platform, Amazon Bazaarknown as Haul in the U.S.to 14 additional international markets, intensifying competition with Chinese e-commerce giants Shein and Temu. The expansion marks...

Meta to Invest $600 Billion in U.S. AI Infrastructure and Job Growth
Nov 08, 2025 01:50 am UTC| Technology Business
Meta Platforms has announced a massive $600 billion investment in U.S. infrastructure and job creation over the next three years, marking one of the largest corporate commitments in recent history. The tech giants primary...

Pfizer Boosts Bid for Metsera Amid Intensifying Rivalry with Novo Nordisk in Obesity Drug Market
Nov 08, 2025 01:48 am UTC| Business Health
Pfizer Inc. has reportedly increased its takeover offer for Metsera, a U.S.-based obesity drug developer, signaling its determination to outpace Danish rival Novo Nordisk in the lucrative weight-loss treatment market....
The “Takaichi Trade”: How Japan’s First Female PM Is Shaping the Yen
How the US–India tariff truce boosts major Indian industries, Surat to Pharma